Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression. (2013)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201206-1028oc

PubMed Identifier: 23087024

Publication URI: http://europepmc.org/abstract/MED/23087024

Type: Journal Article/Review

Volume: 187

Parent Publication: American journal of respiratory and critical care medicine

Issue: 1

ISSN: 1073-449X